Novo Nordisk Foundation · · Instrument: Grants
Challenge Programme
The Novo Nordisk Foundation's Challenge Programme funds ambitious interdisciplinary research projects within themes selected each year, with new calls in open competition every year. The 2027 round offers up to DKK 600 million (EUR 80 million) in grants of up to DKK 75 million over up to six years across four themes: next-generation AMR diagnostics for lower respiratory tract infections, heat and hypertension, electron transfer in hybrid bio-electrocatalysis, and Earth-abundant materials. Applications go through the foundation's NORMA system in two stages, an expression of interest followed by an invited full proposal. The call page for the AMR diagnostics theme shows Stage 1 closing on October 7, 2026 at 2:00pm Copenhagen time, results in December 2026 for Stage 1 and June 2027 for Stage 2, a main applicant at a European (EU, Schengen or UK) institution and at least one applicant in Denmark. The 2026 round awarded up to DKK 600 million across nine grants, announced July 10, 2026, after the programme was opened to European main applicants. The 2025 round awarded up to DKK 478.5 million across four themes including the NNF Grand AI Challenge.
Who can apply
- Eligibility
No separate eligibility field is recorded. Check the program summary and the funder's terms.
- Location
No separate location field is recorded. Check the program summary and the funder's terms.
- Funding
Challenge Programme 2026 round
Up to DKK 600 million across nine grants of up to DKK 75 million
novonordiskfonden.dkChallenge Programme 2027, Stage 1 (AMR diagnostics call)
Up to DKK 150 million for this call; grants of DKK 30 to 75 million
novonordiskfonden.dk
Funding classification
- Instrument
No separate instrument field is recorded. Check the program summary and the funder's terms.
- Capital form
No separate capital form field is recorded. Check the program summary and the funder's terms.
- Allocation method
No separate allocation method field is recorded. Check the program summary and the funder's terms.
- Selection
No separate selection field is recorded. Check the program summary and the funder's terms.
Round history
| Round | Window | Size | Source |
|---|---|---|---|
| Challenge Programme 2027, Stage 1 (AMR diagnostics call) | April 22, 2026 to October 7, 2026Closed | Up to DKK 150 million for this call; grants of DKK 30 to 75 million | novonordiskfonden.dk |
| Challenge Programme 2026 round | Dates not recordedClosed | Up to DKK 600 million across nine grants of up to DKK 75 million | novonordiskfonden.dk |
Past rounds stay on the page, so you can see how often this program opens.
Funding evidence
Detailed funding records are not yet recorded for this program.
Read the program’s recorded facts and sourcesSources
- 01novonordiskfonden.dk/en/challenge-programme
- 02novonordiskfonden.dk/en/challenge-programme/challenge-programme-2025
- 03novonordiskfonden.dk/en/challenge-programme/challenge-programme-2027
- 04novonordiskfonden.dk/en/grant/challenge-programme-2027-advancing-next-generation-amr-diagnostics-for-lower-respiratory-tract-infections
- 05novonordiskfonden.dk/en/news/no-easy-answers-european-research-consortia-take-on-major-challenges
Awards
none linkedNo award records linked to this profile yet.